Non-Communicable Chronic Diseases
10
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Establishing a Physical Activity Referral Scheme for People With Noncommunicable Diseases in the German Healthcare System
Long-term Evaluation of Gestational Endocrine & Metabolic Dynamics
Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases
A Personalized Prevention Program (PPP) Based on the Comprehensive Geriatric Assessment (CGA) for the Prevention of Multidimensional Frailty Related to Non-communicable Chronic Diseases (NCDs) in Older People
Cohort in Qianwan New District, Ningbo
Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi
Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease
Prevalence of NCD Risk Factors in Kazakhstan
The Inland Norway Healthy Life Center Study
Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome